Abstract
Glucocorticoids have been used in the treatment of acute lymphoblastic leukaemia (ALL) for many years, initially as the only agent and then as part of multiagent chemotherapy. In ALL 20% of patients are resistant to glucocorticoids at presentation but this rises to greater than 70% on relapse. It has recently been reported that the glucocorticoid receptor inhibits activity of the AP-1 transcription factor by the ligand-dependant binding of glucocorticoid receptor (GR) to the fos and jun components of AP-1. Since AP-1 is necessary for cell proliferation, the upregulation or over-expression of AP-1 may be a mechanism of resistance to glucocorticoids. The aim of the study was to investigate whether AP-1 levels correlate with in vitro glucocorticoid resistance. In vitro sensitivity to glucocorticoids was measured using the MTT assay. AP-1 levels were quantified using gel shift analysis: a consensus sequence for the AP-1 binding site was synthesised, labelled with 32P and incubated with nuclear extracts of leukaemic blasts from 14 ALL and 26 CLL patients. Leukaemic blasts were treated with prednisolone or with vehicle alone before preparation of nuclear extracts. The gels were dried and bands quantified using a phosphorimager, using an appropriate internal standard and correcting for protein loading and cytoplasmic contamination of nuclear extracts. The patient samples fell into two distinct groups with respect to their sensitivity to glucocorticoids: AP-1 levels were significantly higher (p<0.02) in sensitive blasts than resistant ones. There was no significant change in AP-1 levels after treating blasts for 4 hours with 0.2 mM prednisolone. No change was seen in CLL samples. These data show that glucocorticoid resistance is not associated with increased AP-1. Conversely, glucocorticoid resistance in these samples was apparently associated with decreased AP-1 levels in ALL samples. Whether this has any causal relationship to glucocorticoid resistance is unknown. Clearly, further studies on the role of AP-1 and related transcription factors is essential for understanding the control of proliferation and apoptosis in ALL.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wolff JA, Brubaker CA, Murphy ML, Pierce MI, Severo N. Prednisone therapy of acute childhood leukemia: Prognosis and duration of response in 330 treated patients. Journal of Pediatrics 1967; 70:627–631.
Kaspers GJL, Pieters R, Klumper E, De Waal FC, Veerman AJP. Glucocorticoid resistance in childhood leukaemia. Leukemia and Lymphoma 1994; 13:187–201.
Ashraf J, Thompson EB. Glucocorticoid receptors in leukaemias, lymphomas and myelomas of the young and old. In: Yang S S, Warner H R, eds. The underlaying molecular, cellular, and immunological factors in cancer and aging. New York: Plenum Press, 1993; 241–269.
Helmberg A, Auphan N, Caelles C, Karin M. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 1995; 14:452–460.
Yang-Yen HF, Chambard J, Sun Y, et al. Transcriptional Interference between c-Jun and the Glucocorticoid Receptor: Mutual Inhibition of DNA Binding Due to Direct Protein-Protein Interaction. Cell 1990; 2:1205–1215.
Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochemica et Biophysica Acta 1991; 1072:129–157.
Beato M. Gene regulation by steroid hormones. Cell 1989; 56:335–344.
Costlow ME, Pui C, Dahl GV. Glucocorticoid receptors in childhood acute lymphocytic leukemia. Cancer Research 1982; 42:4801–4806.
Pui C, Ochs J, Kalwinsky DK, Costlow ME. Impact of treatment efficacy on the prognostic value of glucocorticoid receptor levels in childhood acute lymphoblastic leukemia. Leukemia Research 1984; 8:345–350.
Helmberg A, Auphan N, Caelles C, Karin M. Glucocorticoid-induced apoptosis of human leukaemic cells is caused by the repressive function of the glucorticoid receptor. EMBO J 1995; 14:453–460.
Zhou F, Thompson EB. Role of c-jun Induction in the Gluccorticoid-Evoked Apoptotic Pathway in Human Leukemic Lymphoblasts. Molecular Endocrinology 1996; 10:306–316.
Bossy-Wetzel E, Bakiri L, Yaniv M. Induction of apoptosis by the transcription factor c-Jun. EMBO J 1997; 16:1695–1709.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bailey, S., Hall, A.G., Pearson, A.D.J.P., Reid, M.M., Redfern, C.P.F. (1999). Glucocorticoid Resistance and the AP-1 Transcription Factor in Leukaemia. In: Kaspers, G.J.L., Pieters, R., Veerman, A.J.P. (eds) Drug Resistance in Leukemia and Lymphoma III. Advances in Experimental Medicine and Biology, vol 457. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4811-9_68
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4811-9_68
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7180-9
Online ISBN: 978-1-4615-4811-9
eBook Packages: Springer Book Archive